Matrine effectively inhibits the proliferation of breast cancer cells through a mechanism related to the NF-κB signaling pathway

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 517-520

  Shao, Hongmin ^a   Yang, Baowen ^a   Hu, Rongrong ^a   Wang, Yingying ^a  

^a Yantai Traditional Chinese Medical Hospital   (China)

Author keywords

Breast cancer; IKK ; Matrine; NF B

Indexed keywords

3 (4, 5 DIMETHYL 2 THIAZOLYL) 2, 5 DIPHENYLTETRAZOLIUM BROMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84879487888     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1399     Document Type: Article

References (24)

1. Chen F and Huang K: Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB/c mice and MDBK cells. Parasitol Res 111: 1827-1832, 2012.
2. Wan XY, Luo M, Li XD and He P: Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact 181: 15-19, 2009.
3. Jong TT, Lee MR, Chiang YC and Chiang ST: Using LC/MS/MS to determine matrine, oxymatrine, ferulic acid, mangiferin, and glycyrrhizin in the Chinese medicinal preparations Shiau-feng-saan and Dang-guei-nian-tong-tang. J Pharm Biomed Anal 40: 472-477, 2006.
4. Yin LL and Zhu XZ: The involvement of central cholinergic system in (+)-matrine-induced antinociception in mice. Pharmacol Biochem Behav 80: 419-425, 2005.
5. Kobashi S, Takizawa M, Kubo H, Yamauchi T and HigashiyamaK: Antinociceptive effects of N-acyloctahydropyrido[3,2,1-ij][1,6]naphthyridine in mice: structure-activity relation study of matrine-type alkaloids part II. Biol Pharm Bull 26: 375-379, 2003.
6. Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C and Liu J: Antiviral effect of matrine against human enterovirus 71. Molecules 17: 10370-10376, 2012.
7. Zhang S, Zhang Y, Zhuang Y, et al: Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and akt inactivation. PLoS One 7: e46853, 2012.
8. Fu S, Sun C, Tao X and Ren Y: Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Nat Prod Res 26: 1746-1749, 2012.
9. Zhao X, Kan Q, Zhu L and Zhang GX: Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis. Am J Chin Med 39: 933-941, 2011.
10. Xu M, Yang L, Hong LZ, Zhao XY and Zhang HL: Direct protection of neurons and astrocytes by matrine via inhibition of the NF-κB signaling pathway contributes to neuroprotection against focal cerebral ischemia. Brain Res 1454: 48-64, 2012.
11. Zhang J, Li Y, Chen X, et al: Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep 26: 115-124, 2011.
12. Liu XY, Ruan LM, Mao WW, Wang JQ, Shen YQ and Sui MH: Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects. Int J Med Sci 7: 197-208, 2010.
13. Yu P, Liu Q, Liu K, Yagasaki K, Wu E and Zhang G: Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology 59: 219-229, 2009.
14. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ and LederP: The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297-303, 1998.
15. Ting AT, Pimentel-Muiños FX and Seed B: RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J 15: 6189-6196, 1996.
16. Zhang J and Winoto A: A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol 16: 2756-2763, 1996.
17. Karin M, Yamamoto Y and Wang QM: The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3: 17-26, 2004.
18. Yang J, Lin Y, Guo Z, et al: The essential role of MEKK3 in TNF-induced NFκB activation. Nat Immunol 2: 620-624, 2001.
19. Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF: IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281: 998-1001, 1998.
20. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr: NFκB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
21. Kamata H, Honda S, Maeda S, Chang L, Hirata H and KarinM: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005.
22. Broemer M, Krappmann D and Scheidereit C: Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. Oncogene 23: 5378-5386, 2004.
23. Lewis J, Devin A, Miller A, et al: Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 275: 10519-10526, 2000.
24. Park DH, De Xu H, Shim J, et al: Stephania delavayi Diels inhibits breast carcinoma proliferation through the p38 MAPK/NF-κB/COX-2 pathway. Oncol Rep 26: 833-841, 2011.